InvestorsHub Logo
Followers 243
Posts 13901
Boards Moderated 6
Alias Born 01/29/2014

Re: None

Friday, 03/20/2015 8:34:13 PM

Friday, March 20, 2015 8:34:13 PM

Post# of 6169
CRXM - see ticket VBL Tee for the potential on this stock. GENE biotechnology crosses many barriers in the drug landscape. There are already implications the CRXM GENE technology can be used in cancer treatment. The difference, VBL Tee is $6 a share, CRXM is .18 - SAME POTENTIAL + CRXM *already* has FDA approved drugs!

BOOMTOWN
Where The Whales Shop!